FACTREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Factrel, and when can generic versions of Factrel launch?
Factrel is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in FACTREL is gonadorelin hydrochloride. There are seven drug master file entries for this compound. Additional details are available on the gonadorelin hydrochloride profile page.
Summary for FACTREL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FACTREL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FACTREL
US Patents and Regulatory Information for FACTREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-001 | Sep 30, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-002 | Sep 30, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-003 | Sep 30, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FACTREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-002 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-002 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-001 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-003 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-003 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Hikma | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-001 | Sep 30, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FACTREL
See the table below for patents covering FACTREL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 403772 | FORFARANDE FOR FRAMSTELLNING AV DET LH- OCH FSH-FRIGORANDE HORMONET | ⤷ Try a Trial |
United Kingdom | 1425511 | ⤷ Try a Trial | |
France | 2181730 | ⤷ Try a Trial | |
Israel | 41313 | ⤷ Try a Trial | |
United Kingdom | 1425512 | ⤷ Try a Trial | |
Belgium | 865156 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |